One patient with dilated cardiomyopathy in the extra-high BNP group whose symptoms were much improved by dobutamine suffered sudden death due to ventricular fibrillation at 8 days after withdrawal of dobutamine infusion during hospitalization; we excluded this patient from analysis of hospitalization length. The gene discussed is NPPB; the disease is dilated cardiomyopathy.